Bicycle Therapeutics plc - American Depositary Shares (BCYC) earnings
BCYC earnings moved a median of +1.32% by the close. Quarterly and annual BCYC reports and results, each read against the price at its own news timestamp. Back to the BCYC overview →
19 measured BCYC earnings events.
Where these BCYC earnings landedvs 19 measured BCYC earnings reactions
| Middle 50% of BCYC earnings reactions | -0.87% to +4.37% |
|---|---|
| Median reaction (to close) | +1.32% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 BCYC earnings events with a measured close landed between -0.87% and +4.37%; 68% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results | Press release | -0.91% | +3.89% | |
| Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results | Press release | -0.32% | +1.29% | |
| Form 10-K BICYCLE THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | +1.76% | -0.78% | |
| Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results | Press release | +2.32% | +7.09% | |
| Form 10-Q BICYCLE THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | +2.32% | +7.09% | |
| Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results | Press release | +5.17% | +1.32% | |
| Form 10-Q BICYCLE THERAPEUTICS For: Jun 30 | SEC filing · Form 10-Q | +5.17% | +1.32% | |
| Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results | Press release | +1.26% | +4.37% | |
| Form 10-Q BICYCLE THERAPEUTICS For: Mar 31 | SEC filing · Form 10-Q | +1.26% | +4.37% | |
| Form 10-K BICYCLE THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.33% | |
| Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results | Press release | +1.67% | +0.62% | |
| Form 10-Q BICYCLE THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | +1.67% | +0.62% | |
| Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results | Press release | +0.00% | +8.84% | |
| Form 10-Q BICYCLE THERAPEUTICS For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +8.84% | |
| Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results | Press release | +1.00% | -0.96% | |
| Form 10-Q BICYCLE THERAPEUTICS For: Mar 31 | SEC filing · Form 10-Q | +1.00% | -0.96% | |
| Form 10-K BICYCLE THERAPEUTICS For: Dec 31 | SEC filing · Form 10-K | +3.03% | +2.67% | |
| Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day | Press release | +0.00% | -6.05% | |
| Form 10-Q BICYCLE THERAPEUTICS For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -6.05% |
Keep exploring
More BCYC: analyst actions → · SEC filings → · BCYC overview →